The Global Impact Of The Lung Institute Continues To Grow

The Lung Institute at Baylor University has been building a positive reputation around the world since opening its doors in 2014 and has recently seen one of its most respected physicians appear at an Italian conference to discuss how stem cell research and therapies is changing the face of modern medicine. Dr. Jack Coleman recently made the journey to Padua, Italy to speak at the Third Congress on Responsible Stem Cell Research; the journey and speech given by Dr. Coleman has cemented his position and that of The Lung Institute as global leaders in the international stem cell arena. See,

The Lung Institute may be one of the newest entrants into this now global area of medical research and treatments, but the leadership of Dr. David Sugarbaker has been a driving force in bringing the Baylor University affiliated center to a position of global importance. After opening its doors to the public The Lung Institute has worked diligently with many different areas of medical expertise at Baylor University to create a comprehensive testing and treatment program.

In a continued drive for success The Lung Institute has developed a series of areas of expertise ranging from surgical leaders to diagnosis programs that are designed to speed the identification of lung issues in all attending the Institute. According to Cedars-Sinai, Dr. Sugarbaker is a leading expert in mesothelioma and has assembled an experienced and innovative staff with expertise in many different areas of lung research, diagnosis, and treatments at Baylor University.

The expertise of the staff and physicians at The Lung Institute are reflected in the impressive speech given by Dr. Coleman in Padua, Italy about the benefits of stem cell treatments and the problems still facing the medical industry. In his talk Dr. Coleman explained the use of new medicines can often take longer to have a positive effect when compared to the use of stem cell therapies; Dr. Coleman explained an increase in stem cell research and therapies could save lives, but must be regulated to make sure all patients are given fair access to what is currently an expensive therapy to undertake. To read more about the success of stem cell treatment, visit